Healthcare

Firebrick Pharma is a Melbourne-based healthcare company focused on the commercialisation of Nasodine, a nasal spray containing a low concentration of povidone-iodine, an antiviral agent the company positions as an effective treatment for the common cold. Nasodine is currently sold in markets including the …

Patrys Limited (ASX:PAB) has received Human Research Ethics Committee (HREC) approval to commence its Phase 1A clinical trial of RLS-2202 in healthy volunteers, marking a further step in the development of the company’s clinical program.

LTR Pharma Limited (ASX:LTP) has released its FY26 full-year results, outlining progress across its intranasal drug delivery platform, including advancement of SPONTAN through Phase II development, expansion of Australian prescribing activity and preparation for the planned US commercial pathway for ROXUS.

Mach7 Technologies Limited (ASX:M7T) has reported its FY26 results, outlining progress across its healthcare imaging software business, including increasedRecurring Revenuecontribution, cost base restructuring and expansion of its product offering. The company said the second half of FY26 showed improvement across key metrics as it …

Imricor Medical Systems, Inc. (ASX:IMR) has announced the commercial launch of a new interventional MR (iMR) lab solution developed in collaboration with Royal Philips, combining imaging technology and MR-compatible interventional systems for cardiac procedures. The company said the collaboration advances its efforts to support …

IMEXHS (ASX:IME) delivered higher revenue andEarningsin the first half of FY26 while moving its AI-native radiology strategy from launch towards deployment.

ECS Botanics (ASX:ECS) delivered a material improvement in its FY26 financial and operating performance, moving to positive EBITDA and positive operating cash flow while continuing to expand its branded medicinal cannabis portfolio.